Aller au contenu
InsiderTrades
SIGMA
Analyse
Recommandations
TOP
Sélection fondamentale
Terminal
NEW
Sociétés
Dirigeants
Performance
Blog
Topics
FR
FR
FR
FR
Insiders
Trades
Sigma
Sociétés · Santé & Pharma · InsiderTrades Sigma · page 34
Secteur
3 940
Santé & Pharma
Modus Therapeutics Holding AB (publ)
69 M
Modus Therapeutics Holding AB (publ)
Mohini Health & Hygiene Limited
1,1 Md
Molecular Partners AG
115 M
Molecular Partners Ltd
127 M
Molecular Templates, Inc.
Moleculin Biotech, Inc.
14 M
Molina Healthcare, INC.
10 Md
Monopar Therapeutics
398 M
Monte Rosa Therapeutics, Inc.
1,4 Md
MoonLake Immunotherapeutics
1,3 Md
Morepen Laboratories Limited
24 Md
Morphic Holding, Inc.
Motion Acquisition Corp.
Motus GI Holdings, Inc.
638
Mountain Crest Acquisition Corp. III
Movano Inc.
1,7 Md
MultiPlan Corp
MusclePharm Corp
Mustang Bio, INC.
4,6 M
MyMD Pharmaceuticals, Inc.
Myovant Sciences Ltd.
Myriad Genetics INC
429 M
Mysafety Group
451 M
NAN
992 M
NANOBIOTIX
1,4 Md
NASDAQ STOCKHOLM AKTIEBOLAG
NATURAL ALTERNATIVES INTERNATIONAL INC
16 M
NEKTAR THERAPEUTICS
2,4 Md
NEOGEN CORP
1,3 Md
NEOVACS
95
NEPHROS INC
37 M
NETCARE LIMITED
19 Md
NEUROONE MEDICAL TECHNOLOGIES Corp
29 M
NEVRO CORP
NEXGEL, INC.
NFL Biosciences
11 M
NGL Fine-Chem Limited
17 Md
NGM Biopharmaceuticals INC
NICOX SA
41 M
NOLATO AKTIEBOLAG
13 Md
NOVATION COMPANIES, INC.
NOVAVAX INC
1,5 Md
NRX Pharmaceuticals, Inc.
NTI
16 M
NU Skin Enterprises, INC.
264 M
NUVASIVE INC
NUZ
45 M
Nabriva Therapeutics plc
Namn: Vimian Group AB (publ)
← Précédent
Page 34 / 79
Suivant →